Pathological grading of regression: An International Study Group perspective

Journal of Clinical Pathology

Volumn 65, Issue 10, 2012, Pages 865-866

  Chetty, Runjan ^a   Gill, P ^a   Bateman, Adrian C ^b   Driman, David K ^c   Govender, Dhirendra ^d   Bateman, Andrew R ^e   Chua, Y J ^f   Greywoode, Godman ^a   Hemmings, Christine ^g   Imat, I ^h   Jaynes, Eleanor ^b   Lee, Cheok Soon ⁱ   Locketz, Michael ^d   Rowsell, Corwyn ^j   Rullier, Anne ^k   Serra, Stefano ^l   Szentgyorgyi, Eva ^l   Vajpeyi, Rajkumar ^l   Delaney, David ^a   Wang, Lai Mun ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^f CANBERRA HOSPITAL   (Australia)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^h Universidad Pública de Navarra   (Spain)

ⁱ LIVERPOOL HOSPITAL   (Australia)

^j SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^k BORDEAUX UNIVERSITY HOSPITAL   (France)

^l UNIVERSITY HEALTH NETWORK   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROURACIL;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER REGRESSION; EDITORIAL; FIBROSIS; HISTOPATHOLOGY; HUMAN; PATHOLOGY; PRIORITY JOURNAL; RECTUM CANCER;

CHEMORADIOTHERAPY; HUMANS; RECTAL NEOPLASMS;

EID: 84866925521     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2012-201054     Document Type: Editorial

References (21)

1. MacGregor TP, Maughan TS, Sharma AR. Pathological grading of regression following neoadjuvant chemoradiation: the clinical need is now. J Clin Pathol 2012. doi: 10.1136/jclinpath-2012-200958.
2. Valentini V, Aristei C, Glimelius B, et al. Multidisciplinary rectal cancer management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). Radiother Oncol 2009;92:148-63.
3. Janjan NA, Crane C, Feig BW, et al. Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol 2001;24:107-12. (Pubitemid 32323343)
4. Wheeler JM, Warren BF, Mortensen NJ, et al. Quantification of histologic regression of rectal cancer after irradiation: a proposal for a modified staging system. Dis Colon Rectum 2002;45:1051-6.
5. Klautke G, Feyerherd P, Ludwig K, et al. Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer. Br J Cancer 2005;92:1215-20. (Pubitemid 40604394)
6. Rodel C, Martus P, Papadoupolos T, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005;23:8688-96. (Pubitemid 46211512)
7. Maas M, Nelemans PJ, Valentini V, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 2010;11:835-44.
8. Bouzourene H, Bosman FT, Seelentag W, et al. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer 2002;94:1121-30. (Pubitemid 34150868)
9. Ruo L, Tickoo S, Klimstra DS, et al. Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg 2002;236:75-81. (Pubitemid 34686453)
10. Vecchio FM, Valentini V, Minsky BD, et al. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 2005;62:752-60. (Pubitemid 40779765)
11. Min BS, Kim NK, Pyo JY, et al. Clinical impact of tumor regression grade after preoperative chemoradiation for locally advanced rectal cancer: subset analyses in lymph node negative patients. J Korean Soc Coloproctol 2011;27:31-40.
12. Suarez J, Vera R, Gomez M, et al. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer. Colorectal Dis 2008;10:563-8. (Pubitemid 351803062)
13. Rullier A, Laurent C, Capdepont M, et al. Impact of tumor response on survival after radiochemotherapy in locally-advanced rectal carcinoma. Am J Surg Pathol 2010;34:562-8.
14. Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma: clinicopathologic correlations. Cancer 1994;73:2680-6. (Pubitemid 24166250)
15. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997;12:19-23. (Pubitemid 27138353)
16. Chetty R, Gill P, Govender D, et al. A multi-centre pathologist survey on pathological processing and regression grading of colorectal cancer resection specimens treated by neoadjuvant chemoradiation. Virchows Arch 2012;460:151-5.
17. Chetty R, Gill P, Govender D, et al. International Study Group On Rectal Cancer Regression Grading: inter-observer variability with commonly used regression grading systems. Hum Pathol, in press.
18. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420-8.
19. Chua YJ. Pathological complete response: still a relevant endpoint in rectal cancer? Lancet Oncol 2010;11:807-8.
20. Nagtegaal ID, Klein E, Kranenbarg J, et al. Pathology data in the central databases of multicenter randomized trials need to be based on pathology reports and controlled by trained quality managers. J Clin Oncol 2000;18:1771-9. (Pubitemid 30220557)
21. Nagtegaal ID, Marijnen CAM, Kranenbarg EK, et al. Short term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer. J Pathol 2002;197:20-7. (Pubitemid 34450160)